文献速递血栓与止血

原发免疫性血小板减少症中的脂蛋白脂质与载脂蛋白:临床特征及孟德尔随机化分析验证因果关系与识别潜在药物靶点的结果

Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses.
PubMed 文献 · Br J Haematol · 2023-11-30

研究检测原发免疫性血小板减少症(ITP)患者血清总胆固醇、甘油三酯、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇(HDL-C)、载脂蛋白A-I(apoA-I)、apoB、apoE及脂蛋白a水平,并用孟德尔随机化分析遗传变异与ITP的因果关系,结合药物靶点孟德尔随机化与被动ITP小鼠模型探索可成药靶点。结果发现ITP患者HDL-C、apoA-I降低而脂蛋白a升高,低HDL-C与ITP易感性存在因果关联,ABCA1被识别为潜在药物靶点。

要点

  • ITP患者较健康对照HDL-C、apoA-I降低,脂蛋白a升高。
  • 低HDL-C与ITP易感性存在因果关联。
  • ABCA1被识别为ITP潜在药物设计靶点。

核心结论

  • 脂代谢与ITP相关,HDL-C与ITP风险存在因果关联,ABCA1可能是ITP的潜在药物靶点。

研究设计与样本

  • 采用自动生化分析仪检测血清脂质与载脂蛋白水平,并提取与循环脂蛋白脂质及载脂蛋白(LDL-C、apoB、TG、HDL-C、apoA-I)强相关的遗传变异进行孟德尔随机化分析,最后用药物靶点孟德尔随机化与被动ITP小鼠模型探究潜在可成药靶点。

主要发现

  • ITP患者较健康对照HDL-C、apoA-I降低,脂蛋白a升高。
  • 低HDL-C与ITP易感性存在因果关联。
  • 通过药物靶点孟德尔随机化与动物建模,ABCA1被识别为设计ITP药物的潜在靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease. Cellular and systemic lipid metabolism plays a significant role in the regulation of immune cell activities. However, the role of lipoprotein lipids and apolipoproteins in ITP remains elusive. The automatic biochemistry analyser was used to measure the levels of serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A-I (apoA-I), apoB, apoE and lipoprotein a [LP(a)]. Genetic variants strongly associated with circulating lipoprotein lipids and apolipoproteins (LDL-C, apoB, TG, HDL-C and apoA-I) were extracted to perform Mendelian randomization (MR) analyses. Finally, drug-target MR and passive ITP mice model was used to investigate the potential druggable targets of ITP. Levels of HDL-C, apoA-I, decreased and LP(a) increased in ITP patients compared with healthy controls. Low HDL-C was causally associated with ITP susceptibility. Through drug-target MR and animal modelling, ABCA1 was identified as a potential target to design drugs for ITP. Our study found that lipid metabolism is related to ITP. The causative association between HDL-C and the risk of ITP was also established. The study provided new evidence of the aetiology of ITP. ABCA1 might be a potential drug target for ITP.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Ou Y, Zhan Y, Shao X, et al. Lipoprotein lipids and apolipoproteins in primary immune thrombocytopenia: Results from a clinical characteristics and causal relationship verification, potential drug target identification by Mendelian randomization analyses. Br J Haematol. 2023. PMID: 38031970. doi:10.1111/bjh.19229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。